Post-Market Clinical Study on a Modular SI Joint Fusion System

NCT05916092 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2024-02-06

No results posted yet for this study

Summary

A prospective study on the use of the TransLoc 3D SI Joint Fusion System for patients with sacroiliac joint disruptions or degenerative sacroiliitis.

Conditions

  • Sacroiliitis
  • Sacroiliac Joint Dysfunction

Interventions

DEVICE

TransLoc 3D

TransLoc 3D SI Joint Fusion System

Sponsors & Collaborators

  • CornerLoc

    lead INDUSTRY

Principal Investigators

  • Samuel Brown, DO · NY Spine and Pain Specialists

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-19
Primary Completion
2025-12-31
Completion
2026-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05916092 on ClinicalTrials.gov